Israeli CAR-T cancer treatment could be administered out-patient

The therapy was developed at Hadassah to treat Multiple Myeloma, AL Amyloidosis and other BCMA-positive malignancies.

Related Keywords

China ,California ,United States ,Jerusalem ,Israel General ,Israel ,America ,Israeli ,Polina Stepensky ,Cyrillej Cohen ,Shlomit Kfir Erenfeld ,Nathalie Asherie ,Women Zionist Organization Of America ,Bone Marrow Transplantation Department Of Hadassah ,Ilan University ,European Medicines Agency ,Food Drug Administration ,Multiple Myeloma ,Bone Marrow Transplantation Department ,Bar Ilan University ,California Headquartered Immix Biopharma ,Jerusalem Post Women Leaders Summit ,Zionist Organization ,Good Manufacturing Practice ,Drug Administration ,